Two Sigma Advisers
VTAK icon

Two Sigma Advisers’s Catheter Precision VTAK Stock Holding History

Two Sigma Advisers’s Portfolio VTAK Stock Details VTAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2
Closed -$116K – 2736
2020
Q4 		$116K Sell
2
-2
-50% -$119K ﹤0.01% 2251
2020
Q3 		$297K Buy
4
+3
+300% +$239K ﹤0.01% 2015
2020
Q2 		$100K Buy
+1
New +$193K ﹤0.01% 2358

Other funds holding VTAK

RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DY
Dowling & Yahnke San Diego, California $2.15B AUM 10.82% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
EGM
Engineers Gate Manager New York $8B AUM 17.32% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Two Sigma Advisers's VTAK Position: Q1 2021 in Review

Two Sigma Advisers sold out of Catheter Precision (VTAK) in Q1 2021, closing a stake of 2 shares — an estimated $116K sold.

Two Sigma Advisers first reported a position in VTAK in Q2 2020 and held it in 3 quarters. The position peaked at $297K in Q3 2020. 16 funds tracked by Wall St. Rank hold VTAK as of Q1 2021.

  • Two Sigma Advisers reported no remaining Catheter Precision position as of Q1 2021 after selling out during the quarter.
  • Two Sigma Advisers sold 2 Catheter Precision shares in Q1 2021, an estimated $116K.
  • Two Sigma Advisers first reported a position in Catheter Precision in Q2 2020 and held it in 3 quarters.
  • Two Sigma Advisers's Catheter Precision position peaked at $297K in Q3 2020.
  • 16 funds tracked by Wall St. Rank held Catheter Precision as of Q1 2021.

Based on Two Sigma Advisers's 13F filing for Q1 2021, filed 17 May 2021.